Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Pharmaceutical Statistics|July 7, 2023
Modeling immunogenecity data to establish screening bioassays cut pointJorge Quiroz, Satrajit Roychoudhury, Thomas Steinmetz, et al.
Pharmaceutical Statistics|May 19, 2026
Fiducial-Based Statistical Intervals for Bounded Bioanalytical Data Using the Kumaraswamy DistributionJorge Quiroz, Jingwei Xiong, Satrajit Roychoudhury, et al.
Pharmaceutical Statistics|January 16, 2019
A comparative study of confidence intervals to assess biosimilarity from analytical dataJorge Quiroz, Richard Montes, Heliang Shi, et al.
Clinical Pharmacology and Therapeutics|April 1, 2021
Perspectives on Virtual (Remote) Clinical Trials as the "New Normal" to Accelerate Drug DevelopmentDemissie Alemayehu, Robert Hemmings, Kannan Natarajan, et al.
Statistics in Medicine|March 18, 2008
Critical aspects of the Bayesian approach to phase I cancer trialsBeat Neuenschwander, Michael Branson, Thomas Gsponer
Statistics in Medicine|September 8, 2009
A note on the power priorBeat Neuenschwander, Michael Branson, David J Spiegelhalter
Journal of Biopharmaceutical Statistics|January 31, 2023
Assessing adverse events in clinical trials during the era of the COVID-19 pandemicJames Buchanan, Mengchun Li, Barbara Hendrickson, et al.
Biometrics|March 7, 2020
Predictively consistent prior effective sample sizesBeat Neuenschwander, Sebastian Weber, Heinz Schmidli, et al.
Pageof 12